Long Covid

#Biomedical research #Clinical trials #Laboratory data #Long Covid #Neuroscience #Oncology #Trial data

This week in drug discovery (17-21 July)  

News round-up for 17-21 July by DDW Digital Content Editor Diana Spencer. The most impactful drug discovery news this week is all linked with scientific research data. Analysts Phesi revealed that a third of clinical development programmes are cancelled during Phase II, and there were significant… Read More

#News

Long Covid
#Chronic Fatigue Syndrome #Covid-19 #Genetic profiling #Genetics / genomics #Long Covid

Ground-breaking study identifies novel drug targets for long Covid

A study into long Covid has provided the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Despite considerable global research, studies have so far failed to identify the detailed genetic risk factors for long Covid,… Read More

#News #Trending News

#Antibiotics #Cancer vaccine #Drug discovery #HIV #Long Covid #Malaria

This week in drug discovery (10-14 April)

News round-up for 10-14 April by DDW Digital Content Editor Diana Spencer. The headlines getting our attention this week all represent significant breakthroughs in the treatment of various diseases and could make a huge difference to the lives of these patients. Perhaps most significantly,… Read More

#News

Covid-19
#Axcella Therapeutics #Covid-19 #Long Covid #Mitochondria #Phase II trial #University of Oxford

Encouraging trial results for long Covid fatigue treatment

Researchers from the University of Oxford have reported findings from a Phase II clinical trial investigating the efficacy of an investigational treatment against long Covid fatigue. The study found that participants given the treatment, AXA1125, developed by US pharmaceutical company Axcella Therapeutics, felt less fatigued than… Read More

#Editor's Choice #News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

Weekly drug discovery highlights podcast: Listen now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the news this week, we have covered a number of early-stage studies that could… Read More

#News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

This week in drug discovery (13-17 March)

News round-up for 13-17 March by DDW Digital Content Editor Diana Spencer.  In the news this week we have covered a number of early-stage studies that could lead to potentially huge breakthroughs in the treatment of metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune… Read More

#News

Monocyte
#Covid-19 #Immune cells #Immune response #Immunology / Virology & Vaccines #Long Covid

Malfunctioning monocytes could be drug target in long Covid

Researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of long Covid. Normally functioning monocytes, made in the bone marrow, would travel through the blood to the lungs where they surround and kill the… Read More

#Editor's Choice #News

#Autoimmune disease #Biopharmaceuticals #Covid-19 #Long Covid #Multiple sclerosis #Neurodegenerative disorders

€25 million to support clinical developments against long Covid

GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of Covid-19, (PASC, post-Covid or long Covid), has entered into a credit agreement for a total amount of up to €25 million with the… Read More

#News

#Coronavirus #Covid-19 #Long Covid #Omicron

Top stories: Covid-19

An update on the latest Covid-19 news by DDW Digital Content Editor Diana Spencer  With winter around the corner and cases once again on the rise, the last few weeks have seen some interesting developments related to Covid-19. We found out that Omicron infection protects against flu,… Read More

#Covid-19 #News

#Chronic Fatigue Syndrome #Genetics #Long Covid #Myalgic Encephalomyelitis

Study reveals first genetic links in ME and Chronic Fatigue Syndrome

A new study has provided the first detailed genetic insights into the pathophysiological mechanisms underpinning Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).   This is the first time that replicable genetic findings have been reported in over 30 years of study into the disease, potentially offering new approaches for better… Read More

#News

Patient on ventilator
#Covid-19 #Diabetes #Long Covid

Diabetes drug could prevent severe Covid

A recent study by the University of Colorado School of Medicine shows that diabetes drug metformin is effective for preventing severe illness from Covid-19. The CU School of Medicine was part of a multi-site clinical trial into the effectiveness of metformin, ivermectin and fluvoxamine in non-hospitalised adults with Covid-19. … Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Long Covid #Novel therapeutics #Omicron

Is this plant-based therapy a Covid cure? 

The startup company Novel Concepts Medical has announced breakthroughs in its research of Covid-19, which include stopping Covid-19, the Omicron Variant, and long Covid-19 symptoms, including memory loss.   The treatment  Its novel plant-based treatment has resulted in successfully inhibiting the Covid-19 Omicron variant and blocking… Read More

#News